Forbes India - June 4, 2021![Favorilerime ekle Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
Bu konuda
The cover story in this edition is about Sputnik, the third vaccine to get the go-ahead from the Drug Controller of India for emergency use. At least five Indian pharma firms are on track to manufacture 852 million doses of the controversial Russian vaccine. The Hetero Group, for instance, has committed to manufacture 100 million doses. However, concerns around the effectiveness of Sputnik V and the single-dose Sputnik Light remain a cause of worry. Having said that, it is only expected to add to India’s vaccine armoury. That apart, this issue is also a ‘Sustainability Special’ and has stories on efforts across industries to make the planet greener.
Forbes India Magazine Description:
Yayıncı: Digital18
kategori: Business
Dil: English
Sıklık: Fortnightly
Forbes is the world’s leading business magazine and since its inception in 1917, Forbes has stood, unwavering, for one overriding principle: the unshakable belief in the power of free enterprise.
Forbes mission has always been clear and unchanging: to provide insights and information that ensure the success of the world’s most influential. Faithfully fulfilling that promise is what draws today's most influential business leaders to Forbes. These high-powered decision-makers represent a community of like-minded individuals bound by their unshakable belief in the spirit of free enterprise. They contribute to it, profit from it and their lives are better for it. For them, Forbes is the quintessential Capitalist Tool.
True to its pedigree, Forbes India has donned on the role of the drama critic to Indian business. Since its launch in 2009, the magazine has helped readers connect the dots, form patterns and see beyond the obvious, giving them a perspective beyond the obvious.
İstediğin Zaman İptal Et [ Taahhüt yok ]
Sadece Dijital